Back to SYK Overview
NYQ · Valuation Lab
SYK
Stryker Corporation
Last$337.03
Market cap129.3B
EV/EBITDA19.4x
Intrinsic value
$278.92
MoS -20.8% · Overvalued
Assuming 15.9% FCF margin and 9.4% Y1–5 growth.
Upside to price
EV (DCF)119B
Terminal share65%
Expected IV$297.90
Probability weights
Projected free cash flows
Stage FCF path with present values · terminal 65% of EV
PV of stage FCFs42B
PV of terminal value76.9B
Enterprise value119B
Net cash / (debt)-12B
Equity value107B
Intrinsic value / share$278.92
| Year | Revenue | FCF | PV | DF |
|---|---|---|---|---|
| Y1 | 28.3B | 4.5B | 4.2B | 92.9% |
| Y2 | 30.9B | 4.9B | 4.2B | 86.3% |
| Y3 | 33.8B | 5.4B | 4.3B | 80.1% |
| Y4 | 37B | 5.9B | 4.4B | 74.4% |
| Y5 | 40.5B | 6.4B | 4.5B | 69.1% |
| Y6 | 42.4B | 6.7B | 4.3B | 64.2% |
| Y7 | 44.4B | 7.1B | 4.2B | 59.7% |
| Y8 | 46.5B | 7.4B | 4.1B | 55.4% |
| Y9 | 48.7B | 7.7B | 4B | 51.5% |
| Y10 | 50.9B | 8.1B | 3.9B | 47.8% |
| Terminal | — | — | 76.9B | — |
Educational DCF model only — not financial advice. Terminal value and assumptions dominate results; verify filings and run your own diligence.